<img alt="Vasiprak FNB Pvt Ltd" data-src="https://www.vasiprakfnb.com/wp-content/uploads/2021/08/Vasiprak-logo-2.svg" class="logo-dark lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://www.vasiprakfnb.com/wp-content/uploads/2021/08/Vasiprak-logo-2.svg" alt="Vasiprak FNB Pvt Ltd" class="logo-dark" >

<img alt="Vasiprak FNB Pvt Ltd" data-src="https://www.vasiprakfnb.com/wp-content/uploads/2021/08/Vasiprak-logo-White-2.svg" class="logo-light lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw=="><noscript><img src="https://www.vasiprakfnb.com/wp-content/uploads/2021/08/Vasiprak-logo-White-2.svg" alt="Vasiprak FNB Pvt Ltd" class="logo-light" >

Vasiprak FNB Pvt Ltd

Breaking Boundaries since 2018

Vasiprak Blog

Omicron Covid variant

Astrazeneca’s Evusheld retains neutralizing activity against Omicron, Health News, ET HealthWorld

New Delhi: Pharma major AstraZeneca announced that its long-acting antibody combination for the prevention of COVID-19, Evusheld, retained neutralizing activity against the newly detected variant Omicron according to the preclinical…